| Measurement of [(18)F]-fluorodeoxyglucose incorporation into human osteoblast-An experimental method. | |
| | |
MedLine Citation:
|
PMID: 19003012 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
An evaluation of human osteoblast metabolism usually involves measurements of the by-products of bone matrix elaboration. The assessment of glycolytic activity of osteoblasts is not a standard tool in most of the reports, but might be of value by providing a direct indicator of cellular metabolism. Measurement of the incorporation of [(18)F]-fluorodeoxyglucose, which is not further degradable following its conversion into glycose-6-phosphate during glycolysis and is trapped in this form within the cells, can be used as an effective research tool for estimation of osteoblast metabolism. In order to estimate the [(18)F]-fluorodeoxyglucose incorporation we used cultured human osteoblast-like cells. Following incubation of the culture samples in a glucose free medium with 5 mu Ci [(18)F]-fluorodeoxyglucose we measured the radioactivity of the cell fraction, as a percent from the initial dose, and compared to the incorporation values in cells treated by protoporphyrine IX (10(-5) M), an endogenous pro-apoptotic agent. To compare the response of [(18)F]-fluorodeoxyglucose incorporation studies, following treatment of cells with the protoporphyrine IX, to other experimental cell metabolism evaluation methods, we performed a parallel comparison of alkaline phospatase activity, which is a standard measurement tool of osteoblast metabolism, in the control and treatment groups. A narrow range of 0.22-1.36% of [(18)F]-fluorodeoxyglucose incorporation per million cells was found. Additionally in the protoporphyrine IX treated cells a significant 62% decrease of [(18)F]-fluorodeoxyglucose incorporation was observed (p < .05). A parallel significant decrease in alkaline phosphatase activity (p < .001) was found in the cells treated by the protoporphyrine IX. Therefore we suggest that the presented method of [(18)F]-fluorodeoxyglucose incorporation measurement can be utilized as an effective research tool for estimation of the cellular glycolitic activity in human osteoblast-like cells in vitro. |
| | |
Authors:
|
Nahum Rosenberg; Lise Bettman; Orit Rosenberg; Michael Soudry; Moshe Gavish; Rachel Bar-Shalom |
Publication Detail:
|
Type: Journal Article Date: 2007-04-24 |
Journal Detail:
|
Title: Cytotechnology Volume: 54 ISSN: 0920-9069 ISO Abbreviation: Cytotechnology Publication Date: 2007 May |
Date Detail:
|
Created Date: 2008-11-12 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8807027 Medline TA: Cytotechnology Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 1-4 Citation Subset: - |
Affiliation:
|
Department of Orthopaedic Surgery "A", Rambam Medical Center, P.O. 9602, Haifa, 31096, Israel, nahumrosenberg@hotmail.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Analysis of kinetic, stoichiometry and regulation of glucose and glutamine metabolism in hybridoma b...
Next Document: Generation of retroviruses for the overexpression of cytosolic and mitochondrial glutathione reducta...